Dose Optimization of Pembrolizumab: Less May Be More

Mark J. Ratain; Cody J. Peer; William D. Figg; Daniel A. Goldstein

doi:10.1002/cpt.2490

Dose Optimization of Pembrolizumab: Less May Be More

Mark J. Ratain^*, Cody J. Peer, William D. Figg, Daniel A. Goldstein

^*Corresponding author for this work

Oncology

Research output: Contribution to journal › Letter › peer-review

6 Scopus citations

Original language	English
Pages (from-to)	993
Number of pages	1
Journal	Clinical Pharmacology and Therapeutics
Volume	111
Issue number	5
DOIs	https://doi.org/10.1002/cpt.2490
State	Published - May 2022

Funding

Funders	Funder number
National Cancer Institute	ZICSC006537

Access to Document

10.1002/cpt.2490

Cite this

@article{6f323340f4b04fe59bab7c7a65ab38cd,

title = "Dose Optimization of Pembrolizumab: Less May Be More",

author = "Ratain, {Mark J.} and Peer, {Cody J.} and Figg, {William D.} and Goldstein, {Daniel A.}",

note = "Funding Information: No funding was received for this work.",

year = "2022",

month = may,

doi = "10.1002/cpt.2490",

language = "אנגלית",

volume = "111",

pages = "993",

journal = "Clinical Pharmacology and Therapeutics",

issn = "0009-9236",

publisher = "Wiley-Blackwell",

number = "5",

}

TY - JOUR

T1 - Dose Optimization of Pembrolizumab

T2 - Less May Be More

AU - Ratain, Mark J.

AU - Peer, Cody J.

AU - Figg, William D.

AU - Goldstein, Daniel A.

N1 - Funding Information: No funding was received for this work.

PY - 2022/5

Y1 - 2022/5

UR - http://www.scopus.com/inward/record.url?scp=85120382363&partnerID=8YFLogxK

U2 - 10.1002/cpt.2490

DO - 10.1002/cpt.2490

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 34854077

AN - SCOPUS:85120382363

SN - 0009-9236

VL - 111

SP - 993

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

IS - 5

ER -

Dose Optimization of Pembrolizumab: Less May Be More

Funding

Access to Document

Other files and links

Cite this